Novel therapy for myocardial infarction: can HGF/Met be beneficial? (Q28305555)

Cellular and Molecular Life Sciences

Europe PubMed Central

title

Novel therapy for myocardial infarction: can HGF/Met be beneficial? (English)

0 references

main subject

myocardial infarction

1 reference

V Sala

1

0 references

author name string

T Crepaldi

series ordinal

2

0 references

language of work or name

English

0 references

publication date

May 2011

0 references

published in

0 references

volume

68

0 references

issue

10

0 references

page(s)

1703-17

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00018-011-0633-6

0 references

cites work

Targeting the inflammatory response in healing myocardial infarcts

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

21 January 2018

Human cardiac stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Molecular cloning and expression of human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Mechanism of met oncogene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Met, metastasis, motility and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Invasive growth: from development to metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor and its receptor are expressed in cardiac myocytes during early cardiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Emerging multipotent aspects of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor--a new marker for prognosis in acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Therapeutic angiogenesis in the ischemic canine heart induced by myocardial injection of naked complementary DNA plasmid encoding hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Functional and clinical repercussions of myocyte apoptosis in the multifaceted damage by ischemia/reperfusion injury: old and new concepts after 10 years of contributions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor delivered by ultrasound-mediated destruction of microbubbles induces proliferation of cardiomyocytes and amelioration of left ventricular contractile function in Doxorubicin-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Agonist monoclonal antibodies against HGF receptor protect cardiac muscle cells from apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Scatter factor induces blood vessel formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Oncogenic conversion by regulatory changes in transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Immunocomplexes stimulate different signalling events to chemoattractants in the neutrophil and regulate L-selectin and beta 2-integrin expression differently

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

A novel neutrophil-activating factor produced by human mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

The post-natal heart contains a myocardial stem cell population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Pursuing cardiac progenitors: regeneration redux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Cardiac stem cells and mechanisms of myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Cardiac stem/progenitor cells, secreted proteins, and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor expression in the developing myocardium: Evidence for a role in the regulation of the mesenchymal cell phenotype and urokinase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Slug is an essential target of TGFbeta2 signaling in the developing chicken heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Generation of functional ventricular heart muscle from mouse ventricular progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Epicardium-derived cells in cardiogenesis and cardiac regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Development of the coronary vessel system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Epicardial/Mesothelial cell line retains vasculogenic potential of embryonic epicardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

c-kit expression identifies cardiovascular precursors in the neonatal heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor (HGF) enhances cardiac commitment of differentiating embryonic stem cells by activating PI3 kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Therapeutic potential of endothelial progenitor cells in cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Effects of autologous bone marrow stem cell transplantation on beta-adrenoceptor density and electrical activation pattern in a rabbit model of non-ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Contemplating the bright future of stem cell therapy for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Adhesion mechanisms regulating the migration of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Migration of Bone Marrow and Cord Blood Mesenchymal Stem Cells In Vitro Is Regulated by Stromal-Derived Factor-1-CXCR4 and Hepatocyte Growth Factor-c-met Axes and Involves Matrix Metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

CXCR4 and Gab1 cooperate to control the development of migrating muscle progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Treatment of chronical myocardial ischemia by adenovirus-mediated hepatocyte growth factor gene transfer in minipigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor/scatter factor and MET are involved in arterial repair and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Hepatocyte growth factor (HGF) as a potential index of severity of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Protective Role of Interleukin-10 in Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

Mesoangioblasts, Vessel-Associated Multipotent Stem Cells, Repair the Infarcted Heart by Multiple Cellular Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0633-6

HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.

21 January 2018

1 reference

12 December 2020

Chimerism of the transplanted heart

1 reference

12 December 2020

Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen

1 reference

12 December 2020

Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction

1 reference

12 December 2020

A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats

1 reference

12 December 2020

Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts

1 reference

12 December 2020

Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury

1 reference

12 December 2020

Identification of Myocardial and Vascular Precursor Cells in Human and Mouse Epicardium

1 reference

12 December 2020

Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms

1 reference

12 December 2020

Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells

1 reference

12 December 2020

Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion?

1 reference

12 December 2020

Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure

1 reference

12 December 2020

Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction

1 reference

12 December 2020

Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction

1 reference

12 December 2020

The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues.

1 reference

12 December 2020

Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells

1 reference

12 December 2020

Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion

1 reference

12 December 2020

Gene transfer of hepatocyte growth factor improves angiogenesis and function of chronic ischemic myocardium in canine heart

1 reference

12 December 2020

VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells

1 reference

12 December 2020

Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia

1 reference

12 December 2020

Hepatocyte growth factor as a potential index of complication in diabetes mellitus

1 reference

12 December 2020

Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors

1 reference

12 December 2020

Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF

1 reference

12 December 2020

Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis

1 reference

12 December 2020

Co-expression of theHGF/SF andc-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis

1 reference

12 December 2020

Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty

1 reference

12 December 2020

Hepatocyte growth factor expression in the developing myocardium: evidence for a role in the regulation of the mesenchymal cell phenotype and urokinase expression

1 reference

12 December 2020

Short-term safety and curative effect of recombinant adenovirus carrying hepatocyte growth factor gene on ischemic cardiac disease

1 reference

12 December 2020

Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model

1 reference

12 December 2020

Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats

1 reference

12 December 2020

Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells

1 reference

12 December 2020

Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy

1 reference

12 December 2020

Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis

1 reference

12 December 2020

Origin of coronary endothelial cells from epicardial mesothelium in avian embryos

1 reference

12 December 2020

Serum hepatocyte growth factor levels are increased in patients with congestive heart failure

1 reference

12 December 2020

Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features

1 reference

12 December 2020

Hepatocyte growth factor is a regulator of monocyte-macrophage function

1 reference

12 December 2020

Stromal cell-derived factor-1 (SDF-1)\CXCR4 couple plays multiple roles on haematopoietic progenitors at the border between the old cytokine and new chemokine worlds: survival, cell cycling and trafficking.

1 reference

12 December 2020

Isolation and expansion of adult cardiac stem cells from human and murine heart

1 reference

12 December 2020

Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement

1 reference

12 December 2020

A myocardial lineage derives from Tbx18 epicardial cells

1 reference

12 December 2020

1 reference

12 December 2020

Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease

1 reference

12 December 2020

Metabolism of hepatocyte growth factor in the heart in patients with coronary artery disease: implication for coronary arteriosclerosis

1 reference

12 December 2020

Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.

1 reference

12 December 2020

Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure

1 reference

12 December 2020

Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity

1 reference

12 December 2020

Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer

1 reference

12 December 2020

The epicardium as a source of mesenchyme for the developing heart

1 reference

12 December 2020

Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor

1 reference

12 December 2020

Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells

1 reference

12 December 2020

Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells

1 reference

12 December 2020

G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis

1 reference

12 December 2020

Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy

1 reference

12 December 2020

Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts

1 reference

12 December 2020